ROBERTS BRYAN E

Average Profitability
41.14%
Insider Buys Quantity
1
Insider Buys Sum
$11.7M
Insider Sells Quantity
14
Insider Sells Sum
$530.5M

Insider Activity of ROBERTS BRYAN E

The largest purchase of all time was on 2019-09-16 and amounted to 300000 shares of 10x Genomics, Inc. for $11.7M.

The largest sale of all time was on 2020-05-20 and amounted to 6200000 shares of 10x Genomics, Inc. for $483.6M.

Biography of ROBERTS BRYAN E

No biography is available at this moment.

2020-05-20Sale10x Genomics, Inc.
TXG
director
6.2M
6.264%
$78.00$483.6M+82.35%
2019-09-16Purchase10x Genomics, Inc.
TXG
director
300,000
0.7263%
$39.00$11.7M+41.14%
2015-03-10SaleIronwood Pharmaceuticals, Inc.
IRWD
director
7,185
0.005%
$15.17$108,975-24.87%
2015-03-09SaleIronwood Pharmaceuticals, Inc.
IRWD
director
13,296
0.0094%
$15.63$207,814-26.41%
2014-12-15SaleIronwood Pharmaceuticals, Inc.
IRWD
director
2,400
0.0019%
$15.06$36,144-10.26%
2014-12-12SaleIronwood Pharmaceuticals, Inc.
IRWD
director
37,184
0.027%
$15.21$565,569-17.8%
2014-06-12SaleIronwood Pharmaceuticals, Inc.
IRWD
director
200,000
0.1443%
$14.24$2.85M+0.46%
2014-06-09SaleIronwood Pharmaceuticals, Inc.
IRWD
director
577,692
0.4238%
$14.52$8.39M+0.17%
2014-05-30SaleIronwood Pharmaceuticals, Inc.
IRWD
director
822,308
0.6028%
$14.52$11.94M+0.49%
2014-01-14SaleIronwood Pharmaceuticals, Inc.
IRWD
director
42,400
0.0326%
$12.57$532,968+8.6%
2014-01-13SaleIronwood Pharmaceuticals, Inc.
IRWD
director
508,886
0.3976%
$12.57$6.4M+10.32%
2014-01-10SaleIronwood Pharmaceuticals, Inc.
IRWD
director
600,000
0.4689%
$13.12$7.87M+5.49%
2014-01-09SaleIronwood Pharmaceuticals, Inc.
IRWD
director
537,814
0.4149%
$12.40$6.67M+10.05%
2014-01-06SaleIronwood Pharmaceuticals, Inc.
IRWD
director
3,200
0.0026%
$12.06$38,592+17.52%
2014-01-03SaleIronwood Pharmaceuticals, Inc.
IRWD
director
107,700
0.0829%
$12.01$1.29M+12.39%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.